0 147

Cited 14 times in

Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells.

Authors
 Ji Eun Jang  ;  Ju-In Eom  ;  Hoi-Kyung Jeung  ;  June-Won Cheong  ;  Jung Yeon Lee  ;  Jin Seok Kim  ;  Yoo Hong Min 
Citation
 Autophagy, Vol.13(4) : 761-762, 2017 
Journal Title
 Autophagy 
ISSN
 1554-8627 
Issue Date
2017
MeSH
AMP-Activated Protein Kinases/metabolism* ; Antineoplastic Agents/pharmacology* ; Autophagy/drug effects* ; Autophagy-Related Protein-1 Homolog/antagonists & inhibitors* ; Autophagy-Related Protein-1 Homolog/metabolism ; Drug Resistance, Neoplasm/drug effects* ; Humans ; Leukemia, Myeloid, Acute/enzymology ; Leukemia, Myeloid, Acute/pathology* ; Molecular Targeted Therapy* ; Neoplastic Stem Cells/pathology* ; Neoplastic Stem Cells/physiology ; Signal Transduction/drug effects
Keywords
AMPK-ULK1 ; BET inhibitor ; autophagy ; leukemia stem cells ; resistance
Abstract
Bromodomain and extraterminal domain (BET) inhibitors are promising epigenetic agents for the treatment of various subsets of acute myeloid leukemia (AML). However, the resistance of leukemia stem cells (LSCs) to BET inhibitors remains a major challenge. In this study, we evaluated the mechanisms underlying LSC resistance to the BET inhibitor JQ1. We evaluated the levels of apoptosis and macroautophagy/autophagy induced by JQ1 in LSC-like leukemia cell lines and primary CD34+ CD38- leukemic blasts obtained from AML cases with normal karyotype without recurrent mutations. JQ1 effectively induced apoptosis in a concentration-dependent manner in JQ1-sensitive AML cells. However, in JQ1-resistant AML LSCs, JQ1 induced little apoptosis and led to upregulation of BECN1/Beclin 1, increased LC3 lipidation, formation of autophagosomes, and downregulation of SQSTM1/p62. Inhibition of autophagy by pharmacological inhibitors or knockdown of BECN1 using specific siRNA enhanced JQ1-induced apoptosis in resistant cells, indicating that prosurvival autophagy occurred in these cells. Independent of MTOR signaling, activation of the AMPK (p-Thr172)-ULK1 (p-Ser555) pathway was found to be associated with JQ1-induced autophagy in resistant cells. AMPK inhibition using the pharmacological inhibitor compound C or by knockdown of PRKAA/AMPKα suppressed autophagy and promoted JQ1-induced apoptosis in AML LSCs. These findings revealed that prosurvival autophagy was one of the mechanisms involved in the resistance of AML LSCs to JQ1. Targeting the AMPK-ULK1 pathway or inhibition of autophagy could be an effective therapeutic strategy for combating resistance to BET inhibitors in AML and other types of cancer.
Full Text
http://www.tandfonline.com/doi/full/10.1080/15548627.2016.1278328
DOI
10.1080/15548627.2016.1278328
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Jin Seok(김진석) ORCID logo https://orcid.org/0000-0001-8986-8436
Min, Yoo Hong(민유홍) ORCID logo https://orcid.org/0000-0001-8542-9583
Lee, Jung Yoen(이정연)
Jang, Ji Eun(장지은) ORCID logo https://orcid.org/0000-0001-8832-1412
Cheong, June-Won(정준원) ORCID logo https://orcid.org/0000-0002-1744-0921
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/154268
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse